Ibuprofen and pradaxa?

What's the difference between Ibuprofen and Pradaxa?

Ibuprofen and Pradaxa are two medications with different purposes and mechanisms of action. Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve pain, reduce inflammation, and lower fever. It works by blocking the production of prostaglandins, which are chemicals that cause pain and inflammation in the body. [1]

Pradaxa, on the other hand, is an anticoagulant medication used to prevent and treat blood clots in patients at risk of stroke or systemic embolism. It works by inhibiting the activity of factor Xa, a protein in the blood that helps to form clots. [2]

A key difference between the two medications is their potential side effects. Ibuprofen has been associated with gastrointestinal side effects, such as stomach ulcers and bleeding, especially in high doses or with long-term use. Pradaxa, however, has been linked to an increased risk of bleeding, and patients taking the medication should be closely monitored for signs of bleeding or bruising. [3]

How do the patent expirations of these medications impact their availability?

According to DrugPatentWatch.com (drugpatentwatch.com/patent/2021-01-31-Pradaxa/), Pradaxa's (dabigatran etexilate) U.S. patent expires on January 31, 2021.

However, the exact date of Ibuprofen patent expiration isn't publicly provided since patents can vary per country and drug formulation.

Can patients taking Pradaxa use ibuprofen safely?

Generally, it's not recommended to take ibuprofen with Pradaxa due to the increased risk of bleeding. Patients taking Pradaxa should consult their doctor before using ibuprofen, as the risk of bleeding may be higher.

Are there any upcoming biosimilars for Pradaxa?

Several biosimilars for Pradaxa are in development, including those developed by companies like Mylan and Sandoz. However, information on their timelines and regulatory approvals is not currently available.

Sources:
[1] RxList: Ibuprofen (Advil, Motrin)
[2] RxList: Pradaxa (Dabigatran Etexilate)
[3] MedlinePlus: Ibuprofen
[4] drugpatentwatch.com/patent/2021-01-31-Pradaxa/